- Record: found
- Abstract: found
- Article: not found
Transition from IV epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension: a controlled trial.
Melvyn Rubenfire
1 ,
Vallerie V McLaughlin ,
Roblee P Allen ,
Greg Elliott ,
Myung H Park ,
Michael Wade ,
Robert Schilz
Sep 2007
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
We determined the relative efficacy of subcutaneous (SC) treprostinil in stable World Health Organization class II and III patients transitioned from IV epoprostenol.